APA (7th ed.) Citation

Egeberg, A., Hawkes, J. E., Somani, N., Burge, R., See, K., Gallo, G., . . . Armstrong, A. (2024). Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60. Dermatology & Therapy, 14(4), 1007. https://doi.org/10.1007/s13555-024-01147-7

Chicago Style (17th ed.) Citation

Egeberg, Alexander, et al. "Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60." Dermatology & Therapy 14, no. 4 (2024): 1007. https://doi.org/10.1007/s13555-024-01147-7.

MLA (9th ed.) Citation

Egeberg, Alexander, et al. "Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60." Dermatology & Therapy, vol. 14, no. 4, 2024, p. 1007, https://doi.org/10.1007/s13555-024-01147-7.